Gland Pharma reports 15% fall in Q3 consolidated net profit

24 Jan 2023 Evaluate

Gland Pharma has reported results for third quarter ended December 31, 2022.

The company has reported fall of 16.77% in its net profit at Rs 227.54 crore for Q3FY23 as compared to Rs 273.38 crore for the corresponding quarter previous year. Total income of the company decreased by 10.96% to Rs 987.41 crore for the quarter under review as compared to Rs 1,108.99 crore for the same quarter in the previous year.

On the consolidated basis, the company has reported fall of 15.05% in its net profit at Rs 231.95 crore for Q3FY23 as compared to Rs 273.03 crore for the same quarter in the previous year. Total income of the company decreased by 9.85% to Rs 999.80 crore for the quarter under review as compared to Rs 1,108.99 crore for the same quarter in the previous year.

Gland Pharma Share Price

1721.50 56.30 (3.38%)
31-Dec-2025 14:53 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1719.50
Dr. Reddys Lab 1272.50
Cipla 1508.75
Zydus Lifesciences 914.50
Lupin 2110.95
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×